Can we include vaccines with stem-cell transplantation?

被引：11
作者：
Barrett, John [1 ]
Rezvani, Katayoun [2 ]
机构：
[1] NHLBI, Stem Cell Allotransplantat Sect, Hematol Branch, NIH, Bethesda, MD 20892 USA
[2] Univ London Imperial Coll Sci Technol & Med, Dept Hematol, London, England
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2009年 / 6卷 / 09期
关键词：
T-LYMPHOCYTES; LEUKEMIA; RESPONSES; IMATINIB;
D O I：
10.1038/nrclinonc.2009.115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：503 / 505
页数：3
相关论文
共 10 条
[1]  
Bocchia M, 2005, LANCET, V365, P657
[2]   Donor-recipient polymorphism of the proteinase 3 gene: A potential target for T-cell alloresponses to myeloid leukemia [J].
Clave, E ;
Molldrem, J ;
Hensel, N ;
Raptis, A ;
Barrett, AJ .
JOURNAL OF IMMUNOTHERAPY, 1999, 22 (01) :1-6
[3]   Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia [J].
Li, ZH ;
Qiao, Y ;
Liu, B ;
Laska, EJ ;
Chakravarthi, P ;
Kulko, JM ;
Bona, RD ;
Fang, M ;
Hegde, U ;
Moyo, V ;
Tannenbaum, SH ;
Ménoret, A ;
Gaffney, J ;
Glynn, L ;
Runowicz, CD ;
Srivastava, PK .
CLINICAL CANCER RESEARCH, 2005, 11 (12) :4460-4468
[4]   Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells [J].
May, Rena J. ;
Dao, Tho ;
Pinilla-Ibarz, Javier ;
Korontsvit, Tatyana ;
Zakhaleva, Victoriya ;
Zhang, Rong H. ;
Maslak, Peter ;
Scheinberg, David A. .
CLINICAL CANCER RESEARCH, 2007, 13 (15) :4547-4555
[5]   A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique [J].
Mielke, Stephan ;
Nunes, Raquel ;
Rezvani, Katayoun ;
Fellowes, Vicki S. ;
Venne, Annie ;
Solomon, Scott R. ;
Fan, Yong ;
Gostick, Emma ;
Price, David A. ;
Scotto, Christian ;
Read, Elizabeth J. ;
Barrett, A. John .
BLOOD, 2008, 111 (08) :4392-4402
[6]   Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression [J].
Oka, Y ;
Tsuboi, A ;
Taguchi, T ;
Osaki, T ;
Kyo, T ;
Nakajima, H ;
Elisseeva, OA ;
Oji, Y ;
Kawakami, M ;
Ikegame, K ;
Hosen, N ;
Yoshihara, S ;
Wu, F ;
Fujiki, F ;
Murakami, M ;
Masuda, T ;
Nishida, S ;
Shirakata, T ;
Nakatsuka, S ;
Sasaki, A ;
Udaka, K ;
Dohy, H ;
Aozasa, K ;
Noguchi, S ;
Kawase, L ;
Sugiyama, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (38) :13885-13890
[7]   PR1 vaccine elicited immunological response after hematopoietic stem cell transplantation is associated with better clinical response and event-free survival [J].
Qazilbash, Muzaffar H. ;
Wieder, Eric D. ;
Thall, Peter F. ;
Wang, Xuemei ;
Rios, Rosa L. ;
Lu, Sijie ;
Kant, Shreya ;
Giralt, Sergio A. ;
Estey, Elihu H. ;
Cortes, Jorge ;
Komanduri, Krishna ;
Champlin, Richard E. ;
Molldrem, Jeffrey J. .
BLOOD, 2007, 110 (11) :178A-178A
[8]   Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation [J].
Rezvani, Katayoun ;
Barrett, A. John .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2008, 21 (03) :437-453
[9]   Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies [J].
Rezvani, Katayoun ;
Yong, Agnes S. M. ;
Mielke, Stephan ;
Savani, Bipin N. ;
Musse, Laura ;
Superata, Jeanine ;
Jafarpour, Behnam ;
Boss, Carol ;
Barrett, A. John .
BLOOD, 2008, 111 (01) :236-242
[10]   Graft-versus-leukemia effects associated with detectable Wilms tumor-1-specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia [J].
Rezvani, Katayoun ;
Yong, Agnes S. M. ;
Savani, Bipin N. ;
Mielke, Stephan ;
Keyvanfar, Keyvan ;
Gostick, Emma ;
Price, David A. ;
Douek, Daniel C. ;
Barrett, A. John .
BLOOD, 2007, 110 (06) :1924-1932
1